Development and Therapeutic Potential of Calpain Inhibitors
- 1 January 1996
- book chapter
- Published by Elsevier
- Vol. 37, 117-152
- https://doi.org/10.1016/s1054-3589(08)60949-7
Abstract
No abstract availableKeywords
This publication has 182 references indexed in Scilit:
- Synthesis and inhibiting activities of 1-peptidyl-2-haloacetyl hydrazines toward cathepsin B and calpainsEuropean Journal of Medicinal Chemistry, 1993
- Procalpain I in cytoplasm is translocated onto plasma and granule membranes during platelet stimulation with thrombin and then activated on the membranesBiochemical and Biophysical Research Communications, 1992
- Neuronal fodrin proteolysis occurs independently of excitatory amino acid-induced neurotoxicityNeuron, 1991
- Platelet aggregation induced by platelet-activating factor is suppressed by cystine protease inhibitorBiochemical Medicine and Metabolic Biology, 1991
- Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee jointBiochemical and Biophysical Research Communications, 1989
- Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64dBiochemical and Biophysical Research Communications, 1989
- Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpainBiochemical and Biophysical Research Communications, 1988
- Synthesis of a new cell penetrating calpain inhibitor (calpeptin)Biochemical and Biophysical Research Communications, 1988
- Calpain abolishes the effect of filamin on the actomyosin system in plateletsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
- Human plasma α1- and α2-thiol proteinase inhibitors strongly inhibit Ca-activated neutral protease from muscleBiochemical and Biophysical Research Communications, 1983